ATA900385A - Verfahren zur herstellung einer pharmazeutischen zubereitung unter einsatz eines analgetischen und antiinflammatorischen nichtsteroiden wirkstoffes - Google Patents

Verfahren zur herstellung einer pharmazeutischen zubereitung unter einsatz eines analgetischen und antiinflammatorischen nichtsteroiden wirkstoffes

Info

Publication number
ATA900385A
ATA900385A AT0900385A AT900385A ATA900385A AT A900385 A ATA900385 A AT A900385A AT 0900385 A AT0900385 A AT 0900385A AT 900385 A AT900385 A AT 900385A AT A900385 A ATA900385 A AT A900385A
Authority
AT
Austria
Prior art keywords
analgetic
producing
active substance
pharmaceutical preparation
inflammatory non
Prior art date
Application number
AT0900385A
Other languages
English (en)
Other versions
AT390878B (de
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of ATA900385A publication Critical patent/ATA900385A/de
Application granted granted Critical
Publication of AT390878B publication Critical patent/AT390878B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0900385A 1984-02-08 1985-02-08 Verfahren zur herstellung einer pharmazeutischen zubereitung unter einsatz eines analgetischen und antiinflammatorischen nichtsteroiden wirkstoffes AT390878B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/578,288 US4522826A (en) 1984-02-08 1984-02-08 Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Publications (2)

Publication Number Publication Date
ATA900385A true ATA900385A (de) 1990-01-15
AT390878B AT390878B (de) 1990-07-10

Family

ID=24312214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0900385A AT390878B (de) 1984-02-08 1985-02-08 Verfahren zur herstellung einer pharmazeutischen zubereitung unter einsatz eines analgetischen und antiinflammatorischen nichtsteroiden wirkstoffes

Country Status (14)

Country Link
US (1) US4522826A (de)
JP (1) JPH0733331B2 (de)
AT (1) AT390878B (de)
AU (1) AU576825B2 (de)
BE (1) BE901667A (de)
CA (1) CA1251137A (de)
CH (1) CH667392A5 (de)
DE (2) DE3590035T1 (de)
FR (1) FR2559061B1 (de)
GB (1) GB2162747B (de)
IT (1) IT1186181B (de)
NL (1) NL193630C (de)
WO (1) WO1985003443A1 (de)
ZA (1) ZA85840B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643187B2 (en) * 1984-04-09 1993-11-11 Eugene M. Laska Cough-cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU582513B2 (en) * 1984-12-26 1989-03-23 Eugene M. Laska Method for using musculoskeletal relaxants
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
JPH01197444A (ja) * 1986-03-04 1989-08-09 Bristol Myers Co 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンＨ↓１−および／またはＨ↓２−受容体遮断薬との組合せの効果
CH669523A5 (de) * 1986-06-25 1989-03-31 Mepha Ag
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
EP0320550A1 (de) * 1987-12-18 1989-06-21 Bristol-Myers Company NSAID-Zusammensetzungen mit Gehalt an H1-Blockern, H2-Blockern, beta-adrenergischen Agonisten oder Mischungen hiervon und an einem Alkalinisierungsmittel
EP0321613A1 (de) * 1987-12-18 1989-06-28 Bristol-Myers Company Die Wirkung einer Mischung eines beta-adrenergischen Agonisten und gewissen Histamin-H1- und/oder H2-Rezeptorblockern auf gastro-intestinale Beschädigungen, die durch NSAID-Zusammensetzungen hervorgerufen werden
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
WO1992004021A1 (en) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Method for providing improved analgesic effect
US5175152A (en) * 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
AU1252692A (en) * 1991-03-04 1992-10-06 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
AU4325697A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Ibuprofen and diphenhydramine analgesics
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020177626A1 (en) 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
EP1411900B2 (de) 2001-06-01 2013-12-04 Pozen, Inc. Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
JP5211677B2 (ja) * 2007-12-19 2013-06-12 ゼリア新薬工業株式会社 内服液剤
US20090214648A1 (en) * 2008-02-15 2009-08-27 Malathi Kandakatla Pharmaceutical formulations comprising ibuprofen and diphenhydramine
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT194061B (de) * 1955-11-17 1957-12-27 Schering Ag Verfahren zur Herstellung geschmackfreier Zubereitungen basischer Antihistaminika
GB915813A (en) * 1959-12-31 1963-01-16 Biorex Laboratories Ltd Anti-anaphylactic compositions comprising alkanolamines and derivatives thereof
GR71929B (de) * 1979-11-13 1983-08-19 Ici Ltd
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
EP0194547A2 (de) * 1985-03-15 1986-09-17 Miles Laboratories, Inc. Stabile sprudelnde Zusammensetzung aus Acetylsalicylsäure und Diphenhydramin

Also Published As

Publication number Publication date
FR2559061B1 (fr) 1988-04-15
CH667392A5 (de) 1988-10-14
DE3590035C2 (de) 1998-07-09
NL193630B (de) 2000-01-03
FR2559061A1 (fr) 1985-08-09
JPS61501393A (ja) 1986-07-10
AU576825B2 (en) 1988-09-08
DE3590035T1 (de) 1986-03-13
NL193630C (nl) 2000-05-04
CA1251137A (en) 1989-03-14
GB8521793D0 (en) 1985-10-09
GB2162747B (en) 1987-10-21
IT1186181B (it) 1987-11-18
US4522826A (en) 1985-06-11
AU3935685A (en) 1985-08-27
ZA85840B (en) 1985-09-25
GB2162747A (en) 1986-02-12
WO1985003443A1 (en) 1985-08-15
JPH0733331B2 (ja) 1995-04-12
AT390878B (de) 1990-07-10
NL8520027A (nl) 1986-01-02
IT8519382A0 (it) 1985-02-05
BE901667A (fr) 1985-05-29

Similar Documents

Publication Publication Date Title
ATA151587A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
ATA115186A (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
AT385199B (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit verzoegerter wirkstofffreigabe
DE68928482D1 (de) Verfahren zur Herstellung eines Bipolartransistors
ATA60690A (de) Nifedipinpräparate mit einer regulierten wirkstoffabgabe und verfahren zur herstellung derselben
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
DE3677143D1 (de) Film einer graphiteinlagerungsverbindung und verfahren zu dessen herstellung.
ATA245988A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE3769662D1 (de) Verfahren zur herstellung eines stabilen nicorandilpraeparats.
DE3650500D1 (de) Verfahren zur Herstellung eines Verbundsupraleiters
AT385653B (de) Verfahren zur herstellung eines zahnputzmittels
DE58909155D1 (de) Verfahren zur Herstellung eines Bipolartransistors.
AT388670B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung mit einem gehalt an calciumantagonisten
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE68928787D1 (de) Verfahren zur Herstellung eines Bipolartransistors
ATA327685A (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
ATA207887A (de) Verfahren zur herstellung eines pharmazeutischen nicorandilpraeparats zur perkutanen absorption
DE3580390D1 (de) Verfahren zur herstellung eines lactons.
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
ATA89185A (de) Verfahren zur herstellung eines pharmazeutischen mittels zur psoriasis-therapie
ATA26286A (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstoffreisetzung

Legal Events

Date Code Title Description
ELA Expired due to lapse of time